Vivacta Biotechnology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Vivacta Biotechnology - overview
Established
2025
Location
Shanghai, -, China
Primary Industry
Biotechnology
About
Founded in 2025 and based in Shanghai, China, Weitao Biotechnology (Shanghai) Co. , Ltd. conducts research and development in cell and gene technology, supported by collaborations across the medical and scientific communities. The company also engages in international trade and technology consulting to promote global cooperation in biotechnology applications.
Weitao Biotechnology’s business scope includes biotechnology R&D, medical research, and the development of human stem cell and gene-related technologies. The company provides technical services and solutions that support healthcare innovation and life science advancement, with potential applications in disease treatment, regenerative medicine, and genetic analysis. The company generates revenue from biotechnology research services, technology transfer, and the commercialization of gene and cell technology solutions, along with consulting and trade-related activities in the biomedical sector. In April 2026, Vivacta Biotechnology raised USD 50 million in series A funding co-led by Loyal Valley Capital and Decheng Capital, with participation from OrbiMed Advisors, Hankang Capital, Xiamen C&D Emerging Industry Equity Investment, Eisai Innovation, Qiming Venture Partners, Shunxi Fund, and Apricot Capital.
Current Investors
Qiming Venture Partners, Apricot Capital, Shunxi Fund
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Healthcare
Website
www.vivacta-bio.com
Verticals
Nanotechnology
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.